Dependence of lymphocyte surface Ig on continuous polyclonal activation. 1979

D M Bucholz, and S Dray, and M Teodorescu

We have previously shown that most rabbit splenic B cells cultured in a medium supplemented with 5% autologous serum require continuous polyclonal stimulation to maintain detectable amounts of surface Ig. In the absence of this stimulation B cells shed but do not replace their surface Ig. Here, we investigated the mechanism responsible for the loss or maintenance of surface Ig. We showed that the addition of inhibitors of mRNA and protein synthesis to the cell cultures completely abolished the Ig maintenance effect provided by the mitogen thereby suggesting that it did not act by 'freezing' the membrane Ig but rather by continuously stimulating resynthesis. Moreover, by labelling the surface Ig with 125I-labelled Fab anti-allotype antibody we showed that the maintenance of surface Ig by mitogen stimulation was due to the turnover of surface Ig. The cells shed and replaced their surface Ig with a half-life of about 2 h only when mitogen was present but shed without replacing the surface Ig in the absence of mitogen. Also, the B-cell mitogens, SM and LPS, were able to maintain surface Ig even at extremely small concentrations while the T-cell mitogens, Con A and PHA, failed to do so at any concentration, suggesting that direct stimulation of B cells was needed to maintain surface Ig. When spleen cells were cultured in 'crowded' conditions in the absence of mitogen they did not lose their surface Ig; under these conditions it appeared that a factor associated with the macroglobulin fraction is induced and acts in the same manner as a B-cell polyclonal activator to maintain the turnover of surface Ig. Such a factor may actually function in vivo since lymphocytes are in very close contact in the lymphoid organs. We concluded that rabbit B lymphocytes shed and replace their surface Ig with a half-life of about 2 h and that the replacement, but not the shedding of surface Ig, is dependent on continuous exogenous or endogenous polyclonal activation.

UI MeSH Term Description Entries
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D011947 Receptors, Antigen, B-Cell IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment. Antigen Receptors, B-Cell,B-Cell Antigen Receptor,B-Cell Antigen Receptors,Surface Immunoglobulin,Immunoglobulins, Membrane-Bound,Immunoglobulins, Surface,Membrane Bound Immunoglobulin,Membrane-Bound Immunoglobulins,Receptors, Antigen, B Cell,Surface Immunoglobulins,Antigen Receptor, B-Cell,Antigen Receptors, B Cell,B Cell Antigen Receptor,B Cell Antigen Receptors,Bound Immunoglobulin, Membrane,Immunoglobulin, Membrane Bound,Immunoglobulin, Surface,Immunoglobulins, Membrane Bound,Membrane Bound Immunoglobulins,Receptor, B-Cell Antigen,Receptors, B-Cell Antigen
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

D M Bucholz, and S Dray, and M Teodorescu
October 1983, Journal of immunology (Baltimore, Md. : 1950),
D M Bucholz, and S Dray, and M Teodorescu
March 2000, Annales de dermatologie et de venereologie,
D M Bucholz, and S Dray, and M Teodorescu
July 1994, Immunology today,
D M Bucholz, and S Dray, and M Teodorescu
January 1980, Journal of immunology (Baltimore, Md. : 1950),
D M Bucholz, and S Dray, and M Teodorescu
June 1989, Journal of clinical & laboratory immunology,
D M Bucholz, and S Dray, and M Teodorescu
December 1975, Journal of immunology (Baltimore, Md. : 1950),
D M Bucholz, and S Dray, and M Teodorescu
January 1981, Clinical and experimental immunology,
D M Bucholz, and S Dray, and M Teodorescu
January 1981, Minerva stomatologica,
D M Bucholz, and S Dray, and M Teodorescu
January 1976, Scandinavian journal of immunology,
D M Bucholz, and S Dray, and M Teodorescu
November 1990, Journal of virology,
Copied contents to your clipboard!